Abstract |
We examined the profile of two bombesin (BN) antagonists, (CH3)2CHCO-His-Trp-Ala-Val-D- Ala-His-Leu-NHCH3] ( ICI 216140) and [D-Phe6,des-Met14]BN(6-14)ethylamide ( DPDM-BN EA), against neuromedin B-induced Ca2+ mobilization in the small cell lung cancer (SCLC) line NCI-H345. Neuromedin B (NMB), a BN-like peptide sharing sequence homology with ranatensin, elicited a concentration-dependent Ca2+ release (in part) from intracellular stores. Sequential addition of NMB attenuated Ca2+ mobilization. Desensitization occurred between BN and NMB; depletion of intracellular Ca2+ is a likely mechanism because thapsigargin stimulated Ca2+ release after a maximally desensitizing dose of NMB. ICI 216140 and DPDM-BN EA competitively inhibited BN-induced Ca2+ transients. In contrast, these compounds antagonized NMB-stimulated Ca2+ transients in a noncompetitive manner. The pharmacological profiles obtained support receptor heterogeneity for BN-like peptides on this SCLC line, underscoring the need for thorough examination of dose-response relationships when investigating effects of BN analogues on intact cells.
|
Authors | R R Ryan, J L Daniel, A Cowan |
Journal | Peptides
(Peptides)
1993 Nov-Dec
Vol. 14
Issue 6
Pg. 1231-5
ISSN: 0196-9781 [Print] United States |
PMID | 8134305
(Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Oligopeptides
- Peptide Fragments
- bombesin (6-14)-ethylamide, Phe(6)-des-Met(14)-
- ICI 216140
- Neurokinin B
- neuromedin B
- Bombesin
- Calcium
|
Topics |
- Amino Acid Sequence
- Bombesin
(analogs & derivatives, antagonists & inhibitors, pharmacology, physiology)
- Calcium
(metabolism)
- Carcinoma, Small Cell
(metabolism)
- Humans
- Lung Neoplasms
(metabolism)
- Molecular Sequence Data
- Neurokinin B
(analogs & derivatives, antagonists & inhibitors, physiology)
- Oligopeptides
(pharmacology)
- Peptide Fragments
(pharmacology)
- Tumor Cells, Cultured
|